Universita' Degli Studi Di Pavia
Pavia, IT
Universita' Degli Studi Di Pavia Patent applications | ||
Patent application number | Title | Published |
---|---|---|
20160103310 | TWO-PHOTON EXCITATED FLUORESCENCE MICROSCOPE - A two-photon excited fluorescence microscope including a laser source configured to emit a light beam and an optical arrangement configured to receive the light beam from the laser source. The optical arrangement is configured to shape the light beam so that, at an output of the microscope, the light beam is substantially collimated in a first transverse direction perpendicular to the propagation direction of the light beam at the microscope output and is focused in a second transverse direction perpendicular to the first transverse direction and to the propagation direction, thereby forming a line parallel to the first transverse direction. | 04-14-2016 |
20110280952 | Platelet Lysate and Bioadhesive Compositions Thereof for the Treatment of Mucositis - The present invention concerns the use of platelet lysate for treating and/or preventing mucositis. Moreover, a mucoadhesive composition comprising such a platelet lysate for the therapy and/or prevention of mucositis and of corneal lesions is described. | 11-17-2011 |
20090220949 | Mutations Associated with the Long QT Syndrome and Diagnostic Use Thereof - The present invention is based on the identification of new mutations in KCNQ1 (also termed KvLQTI), KCNH2 (also termed HERG), SCN5A, KCNE1 (also termed minK), KCNE2 (also termed MiRP) genes that encode ionic channels involved in cardiac electrical activity and are potentially responsible for the Long QT Syndrome. According to a main aspect, the invention relates to nucleic acids, oligonucleotides and polynucleotides and mRNA, containing sequences of KCNQ1, KCNH2 SCN5A, KCNE1, KCNE2 genes and cDNAs in a mutated form and to respective variant proteins thereof. A preferred embodiment of the present invention is represented by a diagnostic method based on the identification of a group of about 70 non-private mutations in the KCNQ1, KCNH2 and SCN5A genes, detected at high frequency. The method, which is able to identify about 40% of the probands, is non exclusively based on identification of mutations that are described and characterized in this invention where said identification has both prognostic and diagnostic value for the Long QT Syndrome. | 09-03-2009 |